LARGO, FL and CINCINNATI, OH--(Marketwired - Aug 19, 2014) - Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, and Diversified Ophthalmics, Inc. today announced that Diversified has been named an authorized distributor throughout the United States for Unilens' entire C-Vue® family of disposable and C-Vue® Advanced Custom contact lens brands. The lenses are available for sale now through all thirteen Diversified Ophthalmic locations.

"Our new partnership with Diversified Ophthalmics not only expands our C-Vue® brand product availability, it offers an additional channel for independent practitioners that can increase revenue and drive practice profitability," stated Kelly McKnight, Vice President of Sales and Marketing at Unilens Vision Inc. "We are also excited that this partnership will support the launch of our new monthly disposable silicone hydrogel next-generation C-Vue® ADDvantage™ Multifocal for Presbyopia throughout the United States."

"We are very pleased and honored to be chosen to distribute the Unilens family of contact lenses," stated Dr. Ronald F. Cooke, President and CEO of Diversified Ophthalmics, Inc. "Our mutual focus on the needs of independent eye care practitioners and their patients allows the Diversified Ophthalmics team to enthusiastically support the exceptional Unilens products and its professional marketing policies."

C-Vue® disposable brand product offerings available now include the C-Vue® Aspheric Single Vision and 1 Day options, the original C-Vue® Multifocal (in polymacon) and the new disposable C-Vue® ADDvantage™ Multifocal for Presbyopia contact lens in silicone hydrogel material for monthly replacement. The C-Vue® ADDvantage™ incorporates Unilens' highly Advanced next-generation multifocal contact lens design technology, which allows for ease of fit by providing a consistent near ADD power across all power profiles, ultimately resulting in clear vision for presbyopes at all distances. The lens is also thinner and more rounded at the edges for comfort.

About Diversified Ophthalmics, Inc.

Diversified Ophthalmics, Inc. was founded in 1977 by a group of independent eye care practitioners. Their intent was simply to remain competitive with the larger retail chains. From its modest beginning in the basement of an optometric office, Diversified has grown to be among the largest of the ophthalmic suppliers in the country.

Over the past decades, Diversified has kept its focus on meeting the needs of independent eye care practitioners (ECPs). The company has never lost sight of its original goal of allowing independent ECPs to compete with the large "deep pocket" optical chains.

With offices and labs from Spokane, Washington to Columbia, South Carolina and from Milwaukee, Wisconsin to Houston, Texas, Diversified supplies eye care practices in all 50 states. Diversified Ophthalmics, now the 11th largest independently owned laboratory in the US, remains focused on being the Single Source supplier with the quality products, the great service, and the reasonable pricing needed by independent eye care practices.

About Unilens Vision Inc. - "The Independent Eye Care Professionals' Contact Lens Company"

Established in 1989 and headquartered in Largo, Florida, Unilens Vision Inc., through its wholly-owned subsidiaries, Unilens Corp., USA and Unilens Vision Sciences Inc., develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTCQB under the symbol "UVIC".

Forward-Looking Statements

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC.